Atlas Trials

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19

Clinical trial NCT04479202 · COMPLETED

Trial details

NCT number
NCT04479202
Sponsor
Chinese Medical Association
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
BerberineCOVID-19
Start date
2020-02-08
Primary completion
2020-04-18
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.